Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
Clinical trial NCT04544293 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04544293
- Sponsor
- Savara Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-19
- Primary completion
- 2023-11-30
- Enrollment
- 164
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.